After the onset of bronchial asthma, it is necessary to carry out active treatment. In clinical practice, the following categories of bronchodilator drugs are mainly used: The first is adrenergic receptor agonists, such as salbutamol and terbutaline; the second is anticholinergic drugs, mainly tiotropium bromide; the third category is xanthine drugs, which can include aminophylline or doxophylline. Additionally, glucocorticoids can be used for pharmacological treatment. If the patient still has recurrent attacks after systemic treatment, hospitalization is recommended for further management.